2024 Partnership Opportunities

Position Your Brand as A Thought Leader in Integrating Real World Evidence into Clinical Development to Leading European Biopharma

The IMPACCT: Real World Evidence Summit Europe stood as Europe’s only industry-led meeting dedicated to practical case studies of real world evidence across clinical research.

Built with the likes of Pfizer, Sanofi, Novo Nordisk, Janssen and more, this Summit united  80+ key leaders in real world evidence, real world data, evidence generation, and epidemiology who are implementing real world evidence across their development processes.

Our thought leaders from AbbVie, Alexion, Eli Lilly, Novartis, Sanofi and more were looking for long-term partners to support them.

Why Partner in 2025?

Evvent Square (3)

To Provide High Quality Insights

Increase your visibility onsite and position yourself as a thought leader, with the opportunity to deliver a presentation, or join a panel discussion to share your insights with a room full of key decision-makers, showcasing your unique solutions.

Evvent Square (4)

To Meet the Right People

Our meeting will unite VPs, Global Leads, Heads, Executive Directors, Team Leads, and Scientists creating an informal setting so you can network with the key decision-makers in the industry.

Evvent Square (5)

To Foster and Nurture Relationships

Use over 7 hours of networking time to broaden your company’s exposure to the most dedicated individuals, who are keen to integrate RWE into their workflows from AbbVie, Alexion, Alimera Sciences, Chiesi Farmaceutici, Danish Medicines Agency, Eli Lilly, Pfizer, Sanofi, and many more in attendance.

Evvent Square (7)

To Position Your Brand in Front of a Qualified Audience

Benefit from enhanced brand exposure, not only at the event but through pre- and post-conference branding opportunities and logo inclusion across event material and marketing communications, to position yourself as the company of choice and differentiate your product or solution

Who Would You Have Met:

Graph 1 (1)
Graph 2 (2)